Physician profile
Ryan M Taylor
NPI 1508184508
$4,429.29
in general payments reported to CMS, 2019-2025
9 companies · $2,948 in 2025
The $2,948 reported for 2025 was more than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $582 · 2021: $133 · 2022: $380 · 2023: $177 · 2024: $209 · 2025: $2,948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,001 · Food and Beverage: $1,334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,000.93 |
| Food and Beverage | $1,333.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,139.04 | 2019-2025 | Evos, Trigen Intertan, Maverick |
| Stryker Corporation | $789.40 | 2019-2025 | Insignia, Mako, Augment Injectable |
| Medinc of Texas | $138.64 | 2022 | |
| Illuminoss Medical, INC. | $137.91 | 2022 | |
| Arthrex, INC. | $102.99 | 2022 | |
| Ossur Americas, INC. | $60.02 | 2025 | |
| Depuy Synthes Sales INC. | $29.98 | 2019 | |
| Biocomposites INC | $16.52 | 2023 | Stimulan |
| Si-Bone, INC. | $14.79 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.